S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|POZEN Announces U.S. Rights for VIMOVO® to Be Acquired by Horizon Pharma USA, Inc. (2013/11/19)|
|Horizon Pharma Announces Second Quarter 2013 Financial Results and Provides Business Update ()|
|Horizon Pharma Announces Sanofi Compiegne as Additional Manufacturing Site for DUEXIS(R) (2013/9/5)|
|Horizon Pharma Announces Pricing of $150 Million of 5.00% Convertible Senior Notes (2013/11/19)|
|Horizon Pharma Files Patent Infringement Lawsuit Against Watson Laboratories, Inc. - Florida for Filing an ANDA Against RAYOS(R) ()|
|Horizon Pharma Announces Third Quarter 2013 Financial Results, Reports Net Revenue of $26.2 Million (2013/11/8)|
|Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance (2013/11/19)|
|Horizon Pharma Presents New Clinical Data Demonstrating RAYOS(R) (Prednisone) Delayed-Release Tablets Produce a Sustained Reduction in Morning Symptoms in Patients With Rheumatoid Arthritis (2013/10/29)|
|Horizon Pharma Announces Settlement of DUEXIS(R) Patent Litigation With Par Pharmaceutical (2013/8/22)|
|Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (2013/11/12)|
Click above to view more mutual fund data and stats for hznp - Horizon Pharma Inc.